These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1859988)

  • 1. Zidovudine after occupational exposure to HIV.
    BMJ; 1991 Jul; 303(6794):118-9. PubMed ID: 1859988
    [No Abstract]   [Full Text] [Related]  

  • 2. Zidovudine after occupational exposure to HIV.
    Jeffries DJ
    BMJ; 1991 Jun; 302(6789):1349-51. PubMed ID: 2059707
    [No Abstract]   [Full Text] [Related]  

  • 3. Pseudofailure of zidovudine prophylaxis after a human immunodeficiency virus-positive needlestick.
    Lucey D; Milum S; Lindquist C; Andrzejewski C; Benton J; Boswell RN
    J Infect Dis; 1990 Nov; 162(5):1211-2. PubMed ID: 2230250
    [No Abstract]   [Full Text] [Related]  

  • 4. Zidovudine after occupational exposure to HIV.
    Brown EM; Caul EO; Roome AP; Glover SC; Reeves DS; Harling CC
    BMJ; 1991 Oct; 303(6808):990. PubMed ID: 1954431
    [No Abstract]   [Full Text] [Related]  

  • 5. Zidovudine after occupational exposure to HIV.
    BMJ; 1991 Aug; 303(6800):466-7. PubMed ID: 1912844
    [No Abstract]   [Full Text] [Related]  

  • 6. Zidovudine after occupational exposure to HIV.
    BMJ; 1991 Sep; 303(6802):581. PubMed ID: 1912896
    [No Abstract]   [Full Text] [Related]  

  • 7. Zidovudine after occupational exposure to HIV.
    Elkharrat D; Wautier JL; Caulin C; Bonnet N
    BMJ; 1991 Aug; 303(6797):309. PubMed ID: 1888940
    [No Abstract]   [Full Text] [Related]  

  • 8. Zidovudine after occupational exposure to HIV.
    De Wind CM
    BMJ; 1991 Nov; 303(6814):1404. PubMed ID: 1760621
    [No Abstract]   [Full Text] [Related]  

  • 9. Zidovudine after occupational exposure to HIV.
    Nixon D
    BMJ; 1991 Jul; 303(6796):250-1. PubMed ID: 1884077
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV infection after needlesticks.
    White AC; Miller SM
    Ann Intern Med; 1991 Feb; 114(3):253. PubMed ID: 1984757
    [No Abstract]   [Full Text] [Related]  

  • 11. Zidovudine in post-exposure prophylaxis of health-care workers.
    Puro V; Ippolito G
    Lancet; 1990 May; 335(8698):1166-7. PubMed ID: 1971903
    [No Abstract]   [Full Text] [Related]  

  • 12. Is antiretroviral treatment after percutaneous HIV exposure justified?
    Gerberding J
    Ann Intern Med; 1993 Jun; 118(12):979-80. PubMed ID: 8489114
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylactic zidovudine after occupational exposure to the human immunodeficiency virus: an interim analysis.
    Henderson DK; Gerberding JL
    J Infect Dis; 1989 Aug; 160(2):321-7. PubMed ID: 2760486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medically compromised patients, Part II. Current trends in zidovudine chemoprophylaxis post HIV exposure.
    Mito RS; Wahlers M
    J Calif Dent Assoc; 1995 Nov; 23(11):27-31. PubMed ID: 9051999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postexposure use of zidovudine by health-care workers examined in Public Health Service statement.
    Clin Pharm; 1990 Jun; 9(6):403, 406. PubMed ID: 2364644
    [No Abstract]   [Full Text] [Related]  

  • 16. Public health service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use.
    Can Dis Wkly Rep; 1990 Nov; 16 Suppl 2():4-13. PubMed ID: 2292114
    [No Abstract]   [Full Text] [Related]  

  • 17. AIDS: the ultimate occupational accident.
    Standlee JP; Mito RS
    J Calif Dent Assoc; 1991 Apr; 19(4):63-4, 66. PubMed ID: 1719148
    [No Abstract]   [Full Text] [Related]  

  • 18. Zidovudine for chemoprophylaxis after occupational exposure to HIV-infected blood: an economic evaluation.
    Allen UD; Read S; Gafni A
    Clin Infect Dis; 1992 Apr; 14(4):822-30. PubMed ID: 1576276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Emergency Department management of occupational exposures to HIV-infected fluids.
    Evans DW
    J Emerg Med; 2000 Jan; 18(1):121-2. PubMed ID: 10645851
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers.
    D'Amico R; Pinto LA; Meyer P; Landay AL; Harris AA; Clerici M; Berzofsky JA; Shearer GM; Kessler HA
    Infect Control Hosp Epidemiol; 1999 Jun; 20(6):428-30. PubMed ID: 10395147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.